Raymond J. March
| Tuesday August 7, 2018 at 1:39 PM PDT
Off-label information policy reform works to broaden what information drug providers can share.
John R. Graham
| Tuesday August 18, 2015 at 2:07 PM PDT
Judges are chipping away at government censorship of communications about prescription drugs. The Food and Drug Administration exerts great power over a medicine’s label, which describes the medicine’s therapeutic claims. Drug makers and the FDA sometimes spend years negotiating a label. The FDA regulates both safety and “efficacy.” So, a drug maker has to...Read More »